These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 18778183)
41. Drugs for the management of respiratory syncytial virus infection. Broughton S; Greenough A Curr Opin Investig Drugs; 2004 Aug; 5(8):862-5. PubMed ID: 15600242 [TBL] [Abstract][Full Text] [Related]
42. Effectiveness of drug therapies to treat or prevent respiratory syncytial virus infection-related morbidity. Broughton S; Greenough A Expert Opin Pharmacother; 2003 Oct; 4(10):1801-8. PubMed ID: 14521489 [TBL] [Abstract][Full Text] [Related]
43. No effect of cromoglycate treatment in hospitalized infants with respiratory syncytial virus bronchiolitis. Troe JW; Versteegh FG; Mooi-Kokenberg EA; Van den Broeck J Pediatr Pulmonol; 2003 Aug; 36(2):170. PubMed ID: 12833498 [No Abstract] [Full Text] [Related]
44. Pulmonary bacterial co-infection in children ventilated for severe respiratory syncytial virus bronchiolitis is common. Thorburn K; Van Saene H Intensive Care Med; 2007 Mar; 33(3):565. PubMed ID: 17177046 [No Abstract] [Full Text] [Related]
45. Treatment of bronchiolitis in infants. Panitch HB Pediatr Case Rev; 2003 Jan; 3(1):3-19. PubMed ID: 16222134 [No Abstract] [Full Text] [Related]
46. The pharmacologic mechanism by which inhaled epinephrine reduces airway obstruction in respiratory syncytial virus-associated bronchiolitis. Barr FE; Patel NR; Newth CJ J Pediatr; 2000 May; 136(5):699-700. PubMed ID: 10802508 [TBL] [Abstract][Full Text] [Related]
47. Respiratory syncytial virus infection and recurrent wheezing: a complex relationship. Meissner HC; Long SS J Pediatr; 2007 Jul; 151(1):6-7. PubMed ID: 17586181 [No Abstract] [Full Text] [Related]
49. A prospective randomized controlled blinded study of three bronchodilators in infants with respiratory syncytial virus bronchiolitis on mechanical ventilation. Levin DL; Garg A; Hall LJ; Slogic S; Jarvis JD; Leiter JC Pediatr Crit Care Med; 2008 Nov; 9(6):598-604. PubMed ID: 18838938 [TBL] [Abstract][Full Text] [Related]
50. Ribavirin for respiratory syncytial virus bronchiolitis reduced the risk of asthma and allergen sensitization. Chen CH; Lin YT; Yang YH; Wang LC; Lee JH; Kao CL; Chiang BL Pediatr Allergy Immunol; 2008 Mar; 19(2):166-72. PubMed ID: 18257904 [TBL] [Abstract][Full Text] [Related]
56. Prevention of Pediatric Respiratory Syncytial Virus Lower Respiratory Tract Illness: Perspectives for the Next Decade. Aranda SS; Polack FP Front Immunol; 2019; 10():1006. PubMed ID: 31134078 [TBL] [Abstract][Full Text] [Related]
57. Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use. Prais D; Schonfeld T; Amir J; Pediatrics; 2003 Sep; 112(3 Pt 1):548-52. PubMed ID: 12949282 [TBL] [Abstract][Full Text] [Related]
58. Respiratory syncytial virus: how, why and what to do. Rodriguez R; Ramilo O J Infect; 2014 Jan; 68 Suppl 1():S115-8. PubMed ID: 24171820 [TBL] [Abstract][Full Text] [Related]
59. Viral respiratory infection and the link to asthma. Gern JE Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S97-103. PubMed ID: 18820588 [TBL] [Abstract][Full Text] [Related]